Aayush Wellness Limited (BOM:539528)
21.76
-0.38 (-1.72%)
At close: Aug 21, 2026
Aayush Wellness Revenue
Aayush Wellness had revenue of 337.62M INR in the quarter ending June 30, 2026, with 49.18% growth. This brings the company's revenue in the last twelve months to 1.66B, up 95.49% year-over-year. In the fiscal year ending March 31, 2026, Aayush Wellness had annual revenue of 1.55B with 111.98% growth.
Revenue (ttm)
1.66B
Revenue Growth
+95.49%
P/S Ratio
0.64
Revenue / Employee
237.08M
Employees
7
Market Cap
1.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.55B | 821.36M | 111.98% |
| Mar 31, 2025 | 733.46M | 727.43M | 12,063.47% |
| Mar 31, 2024 | 6.03M | -74.99M | -92.56% |
| Mar 31, 2023 | 81.02M | -93.56M | -53.59% |
| Mar 31, 2022 | 174.58M | -1.34B | -88.48% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bal Pharma | 3.34B |
| Parnax Lab | 2.52B |
| Lactose (India) | 1.71B |
| Makers Laboratories | 1.49B |
| Concord Drugs | 860.69M |
| Speciality Medicines | 752.85M |
| Mercury Laboratories | 737.65M |
| Onyx Biotec | 694.69M |